SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001521536-12-000797
Filing Date
2012-08-17
Accepted
2012-08-17 16:47:23
Documents
2
Period of Report
2012-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 q1100690_8ka-biozone.htm 8-K/A 23372
2 filename2.htm CORRESP 16822
  Complete submission text file 0001521536-12-000797.txt   41583
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 333-146182 | Film No.: 121043049
SIC: 2834 Pharmaceutical Preparations